In ovarian cancer, the expression of ACLY is observed to have elevated compared to normal ovarian tissues, and increased expression level of phosphorylated ACLY in ovarian cancer was commonly associated with cancer grade, FIGO stage, and poorer prognosis. This evidence concerns the gene ACLY and ovarian carcinoma.